In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Survey results indicated that cutaneous lupus erythematosus (CLE) significantly affects quality of life (QOL) independently and additively in patients with systemic lupus erythematosus (SLE), with ...

Background: To assess the early alterations in the architecture and performance of the left ventricle for childhood-onset systemic lupus erythematosus (cSLE ... in the SLE cohort received consistent ...

Background: Systemic lupus erythematosus (SLE) is a persistent autoimmune disorder marked by dysregulation of the immune system, resulting in extensive tissue inflammation and subsequent damage.

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive ... and inflammatory causes (Table ...

is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 with the infusion of the 81st patient ...